S100PBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63768998362457E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.87592213669086E-13 |
Normal-vs-Stage2 |
4.23990000000263E-05 |
Normal-vs-Stage3 |
2.57159999961232E-07 |
Normal-vs-Stage4 |
3.35399999995545E-07 |
Stage1-vs-Stage2 |
7.488600E-01 |
Stage1-vs-Stage3 |
3.981400E-01 |
Stage1-vs-Stage4 |
9.573800E-01 |
Stage2-vs-Stage3 |
4.029000E-01 |
Stage2-vs-Stage4 |
8.225200E-01 |
Stage3-vs-Stage4 |
4.878800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.64757096854373E-12 |
Normal-vs-AfricanAmerican |
1.264090E-03 |
Normal-vs-Asian |
5.796600E-03 |
Caucasian-vs-AfricanAmerican |
2.672600E-01 |
Caucasian-vs-Asian |
2.042400E-02 |
AfricanAmerican-vs-Asian |
1.078220E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.18229886886456E-11 |
Normal-vs-Female |
1.0547118733939E-14 |
Male-vs-Female |
4.354300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.937600E-02 |
Normal-vs-Age(41-60Yrs) |
1.70996550252767E-12 |
Normal-vs-Age(61-80Yrs) |
6.24520435366094E-11 |
Normal-vs-Age(81-100Yrs) |
2.602200E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.968600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.597200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.456800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.946180E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.891600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.786400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.61950000263789E-09 |
Normal-vs-Grade 2 |
1.63269398001376E-12 |
Normal-vs-Grade 3 |
1.82750004018573E-09 |
Normal-vs-Grade 4 |
8.20440000000033E-05 |
Grade 1-vs-Grade 2 |
3.360200E-01 |
Grade 1-vs-Grade 3 |
5.950000E-02 |
Grade 1-vs-Grade 4 |
9.154100E-02 |
Grade 2-vs-Grade 3 |
2.914500E-02 |
Grade 2-vs-Grade 4 |
1.133620E-01 |
Grade 3-vs-Grade 4 |
9.373600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
1.86450999999366E-05 |
ccA subtype-vs-ccB subtype |
2.48679999999002E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.87472259938204E-12 |
Normal-vs-N1 |
4.100200E-02 |
N0-vs-N1 |
6.468800E-01 |
|
|